Promotion of Proangiogenic Secretome from Mesenchymal Stromal Cells via Hierarchically Structured Biodegradable Microcarriers.
Promotion of Proangiogenic Secretome from Mesenchymal Stromal Cells via Hierarchically Structured Biodegradable Microcarriers.
复制标题
DOI:
10.1002/adbi.202000062
复制
发表时间:
2020-07
影响因子:
4.1
通讯作者:
Day RM
中科院分区:
文献类型:
--
作者:
Simitzi C;Hendow E;Li Z;Day RM
Adipose‐derived mesenchymal stromal cells (AdMSC) release numerous soluble factors capable of stimulating angiogenesis. Improved methods for delivering these cells to maximize their potency are now sought that ideally they retain viable cells in the target tissue while promoting the secretion of angiogenic factors. Substrate surface topography is a parameter that can be used to manipulate the behavior of AdMSC but challenges exist with translating this parameter into materials compatible with minimally invasive delivery into tissues for in situ delivery of the angiogenic secretome. The current study investigates three compositions of hierarchically structured, porous biodegradable microcarriers for the culture of AdMSC and the influence of their surface topographies on the angiogenic secretome. All three compositions perform well as cell microcarriers in xeno‐free conditions. The attached AdMSC retain their capacity for subsequent trilineage differentiation. The secretome of AdMSC attached to the microcarriers consists of multiple proangiogenic factors, including significantly elevated levels of vascular endothelial growth factor, which stimulates angiogenesis in vitro. The unique properties of hierarchically structured, porous biodegradable microcarriers investigated in this study offer a radically transformative approach for achieving targeted in vivo delivery of AdMSC and enhancing the potency of their proangiogenic activity to induce neovascularization in ischemic tissue. This study investigates highly textured microspheres designed for use as implantable cell microcarriers that are shown to stimulate the secretion of proangiogenic factors from attached mesenchymal stromal cells. These findings suggest that the technology can provide a feasible and transformative new approach for treating cardiovascular disease through the targeted in situ delivery of factors that will promote new blood vessel growth.
登录
查看更多内容
影响因子:
3.7
作者:
Boomsma RA;Geenen DL
通讯作者:
Geenen DL
影响因子:
5.2
作者:
Kasper, Grit;Dankert, Niels;Duda, Georg N.
通讯作者:
Duda, Georg N.
DOI:
10.1073/pnas.0903269107
发表时间:
2010-03-16
影响因子:
11.1
作者:
Kilian, Kristopher A.;Bugarija, Branimir;Mrksich, Milan
通讯作者:
Mrksich, Milan
影响因子:
9.7
作者:
Keshaw, Hussila;Thapar, Nikhil;Day, Richard M.
通讯作者:
Day, Richard M.
影响因子:
4.1
作者:
Abdeen, Amr A.;Weiss, Jared B.;Kilian, Kristopher A.
通讯作者:
Kilian, Kristopher A.